Impact of pre-transplant induction and consolidation cycles on AML allogeneic transplant outcomes: a CIBMTR analysis in 3113 AML patients-Reference-Cited by-同舟云学术

Impact of pre-transplant induction and consolidation cycles on AML allogeneic transplant outcomes: a CIBMTR analysis in 3113 AML patients

Published:2022-10-30 Issue: Volume: Page:
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Boyiadzis Michael,Zhang Mei-Jie,Chen Karen,Abdel-Azim Hisham,Abid Muhammad Bilal,Aljurf Mahmoud,Bacher Ulrike,Badar Talha^ORCID,Badawy Sherif M.,Battiwalla Minoo,Bejanyan Nelli^ORCID,Bhatt Vijaya Raj^ORCID,Brown Valerie I.^ORCID,Castillo Paul^ORCID,Cerny Jan^ORCID,Copelan Edward A.,Craddock Charles^ORCID,Dholaria Bhagirathbhai^ORCID,Perez Miguel Angel Diaz,Ebens Christen L.,Gale Robert Peter^ORCID,Ganguly Siddhartha,Gowda Lohith,Grunwald Michael R.,Hashmi Shahrukh,Hildebrandt Gerhard C.^ORCID,Iqbal Madiha,Jamy Omer,Kharfan-Dabaja Mohamed A.^ORCID,Khera Nandita,Lazarus Hillard M.^ORCID,Lin Richard^ORCID,Modi Dipenkumar^ORCID,Nathan Sunita^ORCID,Nishihori Taiga^ORCID,Patel Sagar S.^ORCID,Pawarode Attaphol,Saber Wael,Sharma Akshay^ORCID,Solh Melhem^ORCID,Wagner John L.,Wang Trent^ORCID,Williams Kirsten M.,Winestone Lena E.^ORCID,Wirk Baldeep^ORCID,Zeidan Amer,Hourigan Christopher S.^ORCID,Litzow Mark^ORCID,Kebriaei Partow^ORCID,de Lima Marcos,Page Kristin,Weisdorf Daniel J.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

https://www.nature.com/articles/s41375-022-01738-3.pdf

Reference27 articles.

1. Dohner H, Estey E, Grimwade D, Amadori S, Appelbaum FR, Buchner T, et al. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood. 2017;129:424–47.

2. Short NJ, Rytting ME, Cortes JE. Acute myeloid leukaemia. Lancet. 2018;392:593–606.

3. Koreth J, Schlenk R, Kopecky KJ, Honda S, Sierra J, Djulbegovic BJ, et al. Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials. JAMA. 2009;301:2349–61.

4. Dholaria B, Savani BN, Hamilton BK, Oran B, Liu HD, Tallman MS, et al. Hematopoietic cell transplantation in the treatment of newly diagnosed adult acute myeloid leukemia: an evidence-based review from the american society of transplantation and cellular therapy. Transpl Cell Ther. 2021;27:6–20.

5. Duval M, Klein JP, He W, Cahn JY, Cairo M, Camitta BM, et al. Hematopoietic stem-cell transplantation for acute leukemia in relapse or primary induction failure. J Clin Oncol. 2010;28:3730–8.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Place de l’allogreffe dans les leucémies aiguës myéloblastiques et syndromes myélodysplasiques de très haut risque (SFGM-TC);Bulletin du Cancer;2024-09

2. CD19 CAR-T treatment shows limited efficacy in r/r DLBCL with double expression and TP53 alterations;Cytotherapy;2024-07

3. Survival after allogeneic transplantation according to pretransplant minimal residual disease and conditioning intensity in patients with acute myeloid leukemia;Frontiers in Oncology;2024-05-02

4. Strategies to reduce relapse risk in patients undergoing allogeneic stem cell transplantation for acute myeloid leukaemia;British Journal of Haematology;2024-04-11

5. Prognostic impact of number of induction courses to attain complete remission in patients with acute myeloid leukemia transplanted with either a matched sibling or human leucocyte antigen 10/10 or 9/10 unrelated donor: An Acute Leukemia Working Party European Society for Blood and Marrow Transplantation study;Cancer;2024-04-06